Research Site — Milan

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

1,414

Registered studies

594

Active

269

Recruiting now

641

Completed

169

Stopped or withdrawn

Most-studied conditions

Ovarian Cancer · Stage II-IIIB Non-small Cell Lung Carcinoma · HR Low-Positive/HER2-Negative Breast Neoplasms · Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.